Multicomponent Telerehabilitation to Engage Veterans in Effective Self-Management of Complex Health Conditions
NCT ID: NCT06288438
Last Updated: 2025-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
126 participants
INTERVENTIONAL
2024-04-18
2028-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Rehabilitation Therapy for Mild Cognitive Impairment
NCT03225482
Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury
NCT00676182
Home-based Telehealth Stroke Care: A Randomized Trial for Veterans
NCT00384748
Tele-rehabilitation for Cognitive Disorders
NCT06795672
Goal-oriented Telehealth Rehabilitation of Executive Functioning for Veterans With Chronic TBI
NCT07190365
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multicomponent Telerehabilitation Intervention (Group 1)
Veterans randomized to the MCTR group will complete the 24-week study intervention consisting of the Active (weeks 1-6), Transition (weeks 7-12), and Sustainability (weeks 13-24) phases. Participants will receive a total of 16 individual sessions (6 integrated, 4 high-intensity rehabilitation, and 6 self-management intervention sessions).
Motivational Interviewing Techniques
Motivational Interviewing Techniques including but not limited to open-ended questions, reflection, affirmations, and summary will be used to build participant rapport, support behavior change (physical activity), and facilitate program engagement.
Physical Therapy Interventions
Strengthening, balance, functional activities, stretching, breathing, aerobic endurance exercise.
Education Control (Group 2)
This group will not receive any exercise intervention but will complete 16 sessions with research staff through videoconferencing. These visits will consist of standardized Health Status Update and education sessions on general health topics.
Education
Education on general health topics which may include the following: basic nutrition, stress reduction, sleep hygiene, etc.
Health Status Updates
Health Status Updates will be completed by a trained assessor. The assessor will ask about adverse events, general health topics, medication changes, and changes in social circumstances.
Physical Therapy Consult
Participants in the control condition will be offered a physical therapy consult at the end of their 24 week study involvement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational Interviewing Techniques
Motivational Interviewing Techniques including but not limited to open-ended questions, reflection, affirmations, and summary will be used to build participant rapport, support behavior change (physical activity), and facilitate program engagement.
Physical Therapy Interventions
Strengthening, balance, functional activities, stretching, breathing, aerobic endurance exercise.
Education
Education on general health topics which may include the following: basic nutrition, stress reduction, sleep hygiene, etc.
Health Status Updates
Health Status Updates will be completed by a trained assessor. The assessor will ask about adverse events, general health topics, medication changes, and changes in social circumstances.
Physical Therapy Consult
Participants in the control condition will be offered a physical therapy consult at the end of their 24 week study involvement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Multiple chronic conditions (Functional Comorbidity Index \> or = 3)
* Impaired physical function (\< or = 8 repetitions on 30 second sit to stand test)
Exclusion Criteria
* Acute or progressive neurological disorder (e.g. amyotrophic lateral sclerosis, recent stroke)
* Moderate to severe dementia (\<11 on telephone Montreal Cognitive Assessment(T-MoCA))
* Medical conditions precluding safe participation in high-intensity rehabilitation (e.g. unstable angina)
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer E. Stevens-Lapsley, PhD
Role: PRINCIPAL_INVESTIGATOR
Rocky Mountain Regional VA Medical Center, Aurora, CO
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-2306
Identifier Type: OTHER
Identifier Source: secondary_id
E5012-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.